In a report released on February 5, Ruben Devos from Kepler Capital maintained a Hold rating on Melexis NV (0FA0 – Research Report), with a ...

Kepler Capital analyst Torsten Sauter maintained a Buy rating on Implenia AG (IPLNF – Research Report) on February 5 and set a price target of ...

Kepler Capital Markets upgraded shares of Logitech International (NASDAQ:LOGI – Free Report) from a hold rating to a buy ...

Frontline plc (NYSE:FRO – Get Free Report) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment ...

Kepler Cheuvreux analysts adjusted their stance on Umicore SA (UMI:BB) (OTC: OTC:UMICY), downgrading the stock from "Buy" to "Hold" and slashing the price target significantly to EUR 10.50 from the ...

Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 – ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on December 31, 2024: ...

Amit Shamir is a managing partner & CEO at Kepler Capital Fund. Amit holds a cum laude BA in Economics and Management from Ben Gurion University and a MBA from Tel-Aviv University.

Those risks include uncertainties inherent in Adocia's short- or medium-term working capital requirements, in research and development, future clinical data, analyses and the evolution of economic ...

LYON, France--(BUSINESS WIRE)--Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 – ADOC) to Kepler Capital Markets, the following resources were ...

Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has a broad ...